Comfort Systems USA And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Comfort Systems USA (FIX), SEI Investments Company (SEIC), ACADIA Pharmaceuticals (ACAD) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Comfort Systems USA (FIX)

31.1% sales growth and 32.93% return on equity

Comfort Systems USA, Inc. provides mechanical and electrical installation, renovation, maintenance, repair, and replacement services for the mechanical and electrical services industry in the United States. It engages in the design, engineering, integration, installation, and start-up of mechanical, electrical, and plumbing (MEP) systems; and renovation, expansion, maintenance, monitoring, repair, and replacement of existing buildings. The company offers its services for heating, ventilation, and air conditioning (HVAC) systems, as well as plumbing, piping and controls, off-site construction, electrical, monitoring, and fire protection. It serves building owners and developers, general contractors, architects, consulting engineers, and property managers in the commercial, industrial, and institutional MEP markets. Comfort Systems USA, Inc. was founded in 1917 and is headquartered in Houston, Texas.

Earnings Per Share

As for profitability, Comfort Systems USA has a trailing twelve months EPS of $11.92.

PE Ratio

Comfort Systems USA has a trailing twelve months price to earnings ratio of 28.4. Meaning, the purchaser of the share is investing $28.4 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.93%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 39.6%, now sitting on 6.08B for the twelve trailing months.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Aug 12, 2024, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 0.35%.

Yearly Top and Bottom Value

Comfort Systems USA’s stock is valued at $338.50 at 11:22 EST, under its 52-week high of $352.45 and way higher than its 52-week low of $151.89.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 44.9% and 34.5%, respectively.

2. SEI Investments Company (SEIC)

10.7% sales growth and 23.74% return on equity

SEI Investments Company is a publicly owned asset management holding company. Through its subsidiaries, the firm provides wealth management, retirement and investment solutions, asset management, asset administration, investment processing outsourcing solutions, financial services, and investment advisory services to its clients. It provides its services to private banks, independent financial advisers, institutional investors, investment managers, investment advisors, wealth management organizations, corporations, retirement scheme sponsors, not-for-profit organizations, hedge fund managers, registered investment advisers, independent broker-dealers, financial planners, life insurance agents, defined-benefit schemes, defined-contribution schemes, endowments, foundations, and board-designated fund, through its subsidiaries. Through its subsidiaries, the firm manages separate client-focused portfolios. It also launches and manages equity, fixed income, and balanced mutual funds, through its subsidiaries. Through its subsidiaries, the firm invests in public equity and fixed income markets. It employs fundamental and quantitative analysis with a focus on top-down and bottom-up analysis to make its investments, through its subsidiaries. SEI Investments Company was founded in 1968 and is based in Oaks, Pennsylvania.

Earnings Per Share

As for profitability, SEI Investments Company has a trailing twelve months EPS of $3.82.

PE Ratio

SEI Investments Company has a trailing twelve months price to earnings ratio of 17.69. Meaning, the purchaser of the share is investing $17.69 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.74%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 20.7% and 20.9%, respectively.

Volume

Today’s last reported volume for SEI Investments Company is 74119 which is 87.44% below its average volume of 590441.

3. ACADIA Pharmaceuticals (ACAD)

10.6% sales growth and 6.7% return on equity

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company also develops Trofinetide, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome; Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-204 for the treatment of Alzheimer's disease psychosis; antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. The company was founded in 1993 and is headquartered in San Diego, California.

Earnings Per Share

As for profitability, ACADIA Pharmaceuticals has a trailing twelve months EPS of $0.19.

PE Ratio

ACADIA Pharmaceuticals has a trailing twelve months price to earnings ratio of 83.84. Meaning, the purchaser of the share is investing $83.84 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.7%.

4. Check Point (CHKP)

5.7% sales growth and 29.55% return on equity

Check Point Software Technologies Ltd. develops, markets, and supports a range of products and services for IT security worldwide. The company offers a multilevel security architecture, cloud, network, mobile devices, endpoints information, and IOT solutions. It provides Check Point Infinity Architecture, a cyber security architecture that protects against fifth generation cyber-attacks across various networks, endpoint, cloud, workloads, Internet of Things, and mobile. In addition, the company offers security gateways and software platforms that support small and medium sized business. Further, it provides cloud network security, cloud native application protection, security and posture management, cloud identity and entitlement, cloud workload protection, cloud detection and response, and cloud web application protection for web applications and APIs; and Check Point Harmony that delivers endpoint and secure connectivity for remote user access. Additionally, the company offers technical customer support programs and plans; professional services in implementing, upgrading, and optimizing Check Point products comprising design planning and security implementation; and certification and educational training services on Check Point products. It sells its products through distributors, resellers, system integrators, original equipment manufacturers, and managed security service providers. Check Point Software Technologies Ltd. was incorporated in 1993 and is headquartered in Tel Aviv, Israel.

Earnings Per Share

As for profitability, Check Point has a trailing twelve months EPS of $7.1.

PE Ratio

Check Point has a trailing twelve months price to earnings ratio of 22.78. Meaning, the purchaser of the share is investing $22.78 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.55%.

Moving Average

Check Point’s worth is under its 50-day moving average of $176.77 and above its 200-day moving average of $160.90.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 8.7% and 3.1%, respectively.

Sales Growth

Check Point’s sales growth is 7.3% for the present quarter and 5.7% for the next.

Previous days news about Check Point(CHKP)

  • According to Zacks on Tuesday, 3 September, "Compared to its peers, Palo Alto Networks stock has left competitors like Juniper Networks, Inc. (JNPR Quick QuoteJNPR – Free Report) and Check Point Software Technologies Ltd. ", "For comparison, Juniper Networks and Check Point Software trade at more modest multiples of 2.48X and 8.18X, respectively."

Leave a Reply

Your email address will not be published. Required fields are marked *